Pharmtech
Delivery of therapeutics to the human eye is one of the most interesting—but challenging—endeavors a formulator can take on. The anatomy and chemical composition of the eye make it highly resistant to pharmaceutical penetration. Successfully circumventing these protective barriers requires intimate knowledge of ocular delivery as well as specialized development and manufacturing expertise.
Watch Now
Pharmacy needs to build sustained data and analytics capabilities that support evidence-based decision making and advocacy interventions that inform policy development.
Watch Now
The Drug Supply Chain Security Act (DSCSA) has its final deadline approaching in November 2023. To confirm that only trusted entities are involved in the exchange of prescription drugs, one of the lesser thought-about elements mandates that the required data exchange through the supply chain is only done with authorized and registered trading partners.
Watch Now
Abcam plc
What makes a good potential target for drug discovery? Listen in as Dr. Elizabeth Glennon, of King's College London, discusses how the disruption of axonal transports early on within Alzheimer's Disease provides excellent targets for drug discovery. How the disruption of axonal transport contributes to the development of Alzheimer's disease. Mechanisms of axonal transport of the Alzheimer's amyloid precursor protein, and how these are altered in the disease.
Watch Now